Nautilus Biotechnolgy, Inc. Common Stock
NAUT US63909J1088
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Patel Sujal M CEO |
0.68 USD |
83,500 Bought |
57,031 USD |
05/09/2025 | 08/09/2025 |
Patel Sujal M CEO |
0.67 USD |
116,500 Bought |
78,544 USD |
05/09/2025 | 05/09/2025 |
Murphy Matthew B. SR OFF |
0.64 USD |
20,000 Bought |
12,858 USD |
04/09/2025 | 04/09/2025 |
Mowry Anna CFO |
0.77 USD |
15,000 Bought |
11,489 USD |
29/05/2025 | 29/05/2025 |
Mowry Anna CFO |
0.77 USD |
15,000 Bought |
11,489 USD |
29/05/2025 | 29/05/2025 |
Mallick Parag SR OFF |
0.73 USD |
1,500 Bought |
1,098 USD |
08/05/2025 | 12/05/2025 |
Mallick Parag SR OFF |
0.73 USD |
1,500 Bought |
1,098 USD |
08/05/2025 | 12/05/2025 |
Mallick Parag SR OFF |
0.73 USD |
12,000 Bought |
8,788 USD |
08/05/2025 | 08/05/2025 |
Mallick Parag SR OFF |
0.73 USD |
12,000 Bought |
8,788 USD |
08/05/2025 | 08/05/2025 |
Patel Sujal M CEO |
1.00 USD |
23,933 Bought |
23,890 USD |
19/03/2025 | 20/03/2025 |